IP Library Granted Patent US 6,997,918
Granted Patent B2
US 6,997,918 · App. 10/382,131 · Granted Feb 14, 2006

Methods and devices for obstructing and aspirating lung tissue segments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,997,918
App. No.
10/382,131
Granted
Feb 14, 2006
Kind
B2
Abstract

The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used. The obstructive device may remain as an implant, to maintain isolation and optionally allow subsequent aspiration, or the device may be removed at any time.

Claims (24)

1. A method for lung volume reduction, said method comprising:

deploying an obstructive device in a lung passageway to a lung tissue segment;

passing an access tube through the obstructive device;

aspirating the segment through the access tube through the deployed obstructive device to at least partially collapse the lung segment, wherein the obstructive device is left in place as an implant after aspiration is complete, wherein the aspirating comprises coupling an aspiration catheter to the access tube and aspirating gas through the catheter from the lung segment.

2. A method as in claim 1 , wherein the obstructive device comprises a self-sealing septum and passing comprises piercing the access tube through the septum.

3. A method as in claim 2 , wherein the septum comprises a solid membrane or a pre-cut membrane.

4. A method as in claim 1 , wherein aspirating comprises:

advancing an aspiration catheter into the lung passageway toward the obstructive device, wherein the aspiration catheter has an occlusion balloon near its distal end;

inflating the occlusion balloon to substantially occlude the lung passageway proximal to the obstructive device; and

aspirating gas through the access tube and the catheter.

5. A method as in claim 1 , wherein the obstructive device comprises a structural support and deploying comprises expanding the structural support so that it anchors in the passageway.

6. A method as in claim 5 , wherein the structural support comprises a self-expanding support and expanding comprises releasing the self-expanding support from constraint so that it expands and thereby anchors in the passageway.

7. A method as in claim 6 , wherein deploying further comprises inflating a balloon which expands the structural support.

8. A method as in claim 1 , further comprising positioning an access catheter in the lung passageway prior to deployment of the obstructive device, said access catheter having a proximal end, a distal end, and at least one lumen extending therethrough.

9. A method as in claim 8 , wherein the access catheter has an occlusion balloon near its distal end and aspirating comprises:

inflating the occlusion balloon to substantially occlude the lung passageway proximal to the obstructive device; and

aspirating gas through the access tube and the catheter.

10. A method as in claim 9 , wherein the access catheter provides optical imaging.

11. A method as in claim 9 , wherein the access catheter is steerable.

12. A method as in claim 9 , wherein the access catheter is positioned with the use of a guidewire.

13. A method as in claim 12 , wherein the guidewire provides imaging capabilities.

14. A method as in claim 1 , further comprising introducing a gas or liquid to the segment prior to aspiration.

15. A method as in claim 14 , wherein the gas comprises 100% oxygen, a Helium-Oxygen mixture or a low molecular weight gas.

16. A method as in claim 14 , wherein the liquid comprises perfluorocarbon or a drug.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2010
From: SOLTESZ, PETER P.; KOTMEL, ROBERT; WONDKA, TONY; REILLY, MICHAEL P.; BUCH, WALLY S.
To: PULMONX
Reel/Frame 023870/0457 →